Not applicableStudy completedNCT03408106What this trial is testingProspective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ RecipientsWho this might be right forHIV Infections Johns Hopkins University 3
Not applicableUnknownNCT01687504What this trial is testingPharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in GhanaWho this might be right forTuberculosisHIV The Miriam Hospital 106
Not applicableStudy completedNCT01716299What this trial is testingComparison of HIV Testing AlgorithmsWho this might be right forHIV Infection Medecins Sans Frontieres, Netherlands 495
Not applicableStudy completedNCT00002398What this trial is testingSafety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug CombinationsWho this might be right forHIV Infections Gilead Sciences
Not applicableStudy completedNCT03616106What this trial is testingInformation Visualizations to Facilitate HIV-related Patient-provider Communication (Info Viz: HIV)Who this might be right forHealth Communication Columbia University 59
Not applicableStudy completedNCT00440206What this trial is testingMulticenter Trial of Immunologic Markers to Predict Long Term Virologic OutcomesWho this might be right forHIV Infections Ottawa Hospital Research Institute 50
Not applicableStudy completedNCT00067704What this trial is testingEmotional Disclosure in HIVWho this might be right forHIV Infections University of Miami 283
Early research (Phase 1)Study completedNCT04658667What this trial is testingHIV Vaccine in HIV-uninfected AdultsWho this might be right forHIV U.S. Army Medical Research and Development Command 81
Testing effectiveness (Phase 2)Study completedNCT04533399What this trial is testingA Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African AdultsWho this might be right forSARS-CoV-2 InfectionCOVID-19 Novavax 4,422
Not applicableStudy completedNCT03451032What this trial is testingRegional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIVWho this might be right forHiv Nantes University Hospital 150
Early research (Phase 1)Study completedNCT05204121What this trial is testingPhase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy VolunteersWho this might be right forHIV Infections Viriom 36
Large-scale testing (Phase 3)Active Not RecruitingNCT07047716What this trial is testingStudy of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)Who this might be right forHIV Pre-exposure Prophylaxis Gilead Sciences 339
Early research (Phase 1)Study completedNCT00124007What this trial is testingSafety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableStudy completedNCT03868644What this trial is testingThe Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in KenyaWho this might be right forHIV/AIDSHSV-2 Infection Abdul Latif Jameel Poverty Action Lab 10,646
Not applicableUnknownNCT02529644What this trial is testingChurch-based HIV Screening: Taking It to the PewsWho this might be right forHIV University of Missouri, Kansas City 1,540
Early research (Phase 1)Study completedNCT00058734What this trial is testingTherapeutic Vaccination Followed by Treatment Interruption in HIV Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 5
Post-approval studies (Phase 4)Study completedNCT02724852What this trial is testingMMR Vaccination Among HIV-infected AdultsWho this might be right forHIV Chiang Mai University 632
Not applicableActive Not RecruitingNCT05454852What this trial is testingPreferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in ZambiaWho this might be right forHIV Boston University 771
Post-approval studies (Phase 4)Study completedNCT00718536What this trial is testingClinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral TherapyWho this might be right forHIV Infections Germans Trias i Pujol Hospital 15
Not applicableStudy completedNCT03979144What this trial is testingUsability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) ScreeningWho this might be right forMass Screening The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 113